The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-dose lenalidomide and melphalan as conditioning for autologous stem cell transplantation in relapsed or refractory multiple myeloma.
 
Adriana C. Rossi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Takeda
Research Funding - BMS Brazil
 
Jorge Monge
No Relationships to Disclose
 
Ruben Niesvizky
Honoraria - Amgen; Bio Ascend; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Biotech; Karyopharm Therapeutics; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Biotech; Karyopharm Therapeutics; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Karyopharm Therapeutics (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bio Ascend; Celgene; Janssen Biotech; Karyopharm Therapeutics; Takeda
 
Jing Mei Hsu
No Relationships to Disclose
 
Tsiporah Shore
No Relationships to Disclose
 
Koen Van Besien
Stock and Other Ownership Interests - HemOgenyx
Consulting or Advisory Role - Actinium Pharmaceuticals; Cellectis
Research Funding - Actinium Medical Advisory Board; Juno Therapeutics; Miltenyi Biotec
 
Roger Pearse
No Relationships to Disclose
 
Tomer Mark
No Relationships to Disclose
 
David Jayabalan
No Relationships to Disclose
 
Sebastian Alexander Mayer
No Relationships to Disclose